Publications by authors named "Barry Quart"

Claim this Profile
R
Response to the letter to the editor by Hafer and Johnson concerning 'Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain'.
Thomas Ottoboni, Barry Quart, Jayne Pawasauskas, Joseph F Dasta, Richard A Pollak

Reg Anesth Pain Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain.
Thomas Ottoboni, Barry Quart, Jayne Pawasauskas, Joseph F Dasta, Richard A Pollak

Reg Anesth Pain Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HTX-019 via 2-min injection or 30-min infusion in healthy subjects.
Thomas Ottoboni, Michael Lauw, Mary Rose Keller, Matt Cravets, Kimberly Manhard, Barry Quart

Future Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of HTX-019 (intravenous aprepitant) and fosaprepitant in healthy subjects.
Tom Ottoboni, Michael Lauw, Mary Rose Keller, Matt Cravets, Kimberly Manhard, Barry Quart

Future Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence of HTX-019 (aprepitant IV) and fosaprepitant in healthy subjects: a Phase I, open-label, randomized, two-way crossover evaluation.
Tom Ottoboni, Mary Rose Keller, Matt Cravets, Neil Clendeninn, Barry Quart

Drug Des Devel Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Lesinurad in Combination With Allopurinol on Serum Uric Acid Levels in Patients With Gout.
Scott Baumgartner, Li-Tain Yeh, Zancong Shen, Bradley Kerr, Kimberly Manhard, Barry Quart

J Clin Pharmacol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
Jeffrey N Miner, Philip K Tan, David Hyndman, Sha Liu, Cory Iverson, Barry Quart

Arthritis Res Ther· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
Jeffrey N Miner, Philip K Tan, David Hyndman, Sha Liu, Cory Iverson, Barry Quart

Arthritis Res Ther· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males.
Zancong Shen, Colin Rowlings, Brad Kerr, Vijay Hingorani, Kimberly Manhard, Barry Quart

Drug Des Devel Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.
Roy Fleischmann, Bradley Kerr, Li-Tain Yeh, Matt Suster, Zancong Shen, Barry Quart

Rheumatology (Oxford)· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2a randomized controlled trial of short-term activity, safety, and pharmacokinetics of a novel nonnucleoside reverse transcriptase inhibitor, RDEA806, in HIV-1-positive, antiretroviral-naive subjects.
Graeme Moyle, Marta Boffito, Albrecht Stoehr, Armin Rieger, Zancong Shen, Barry Quart

Antimicrob Agents Chemother· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer.
Cory Iverson, Gary Larson, Chon Lai, Li-Tain Yeh, Claudia Dadson, Barry Quart

Cancer Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis